Vertical: CNMBase Year: 2025
Market Size (2025)
$296.81M
Projected (2032)
$408.65M
CAGR (2022–2032)
4.7%
Key Players
12+
Market Overview
The Global Feed Mycotoxin Detoxifiers Market was valued at USD 296.81 Million in 2025 and is projected to reach USD 408.65 Million by 2032, expanding at a CAGR of 4.67% during 2026–2032. The market has grown steadily from USD 258.72 Million in 2022, and the forecast period is expected to add USD 111.84 Million in absolute value between 2025 and 2032.
Feed mycotoxin detoxifiers are feed additives that reduce the exposure of livestock to mycotoxins, the toxic secondary metabolites produced by Aspergillus, Fusarium and Penicillium moulds on cereals, oilseeds and their by-products. The market comprises two product classes: binders, which adsorb mycotoxins in the gastrointestinal tract and prevent their absorption, and modifiers, which transform mycotoxins into non-toxic metabolites through enzymatic or microbial action. Demand is underpinned by the persistent and rising incidence of multi-mycotoxin contamination in feed raw materials, the expansion of global compound feed production, and progressively tighter regulatory limits for mycotoxins in feed and in animal-derived food.
Key Findings
Product Type: Binders was the largest segment in 2025 with a 70.0% share (USD 207.76 Million), while Modifiers is the fastest-growing segment with a CAGR of 6.17% during 2026–2032.
Livestock: Poultry held the largest share at 45.0% in 2025 (USD 133.56 Million) and is also the fastest-growing livestock segment, with a CAGR of 5.14%.
Region: Asia Pacific was the leading region in 2025 with USD 94.98 Million (32.0% share) and is the fastest-growing region with a CAGR of 5.66%. Europe records the slowest growth at a CAGR of 3.72%.
Country: The U.S. was the leading country in 2025 with USD 50.28 Million, while India is the fastest-growing country with a CAGR of 7.42% during 2026–2032.
Segmentation Summary
By product type, binders remain the backbone of the market owing to their low cost per tonne of feed, long history of use, and effectiveness against aflatoxins. Binders are expected to grow from USD 207.76 Million in 2025 to USD 272.68 Million by 2032, registering a CAGR of 3.98% during 2026–2032. Modifiers, which include enzymes and microorganisms that biotransform mycotoxins such as fumonisins, trichothecenes and zearalenone that are poorly adsorbed by clays, are projected to grow from USD 89.04 Million in 2025 to USD 135.97 Million by 2032, registering a CAGR of 6.17% during 2026–2032, gaining share throughout the forecast period.
By livestock, poultry accounts for the largest share because of the scale of global broiler and layer feed production and the high sensitivity of young birds to aflatoxins and trichothecenes. Swine, valued at USD 89.04 Million in 2025, is the second-largest segment, supported by the well-documented sensitivity of pigs to deoxynivalenol and zearalenone. Ruminants & Others, valued at USD 74.20 Million in 2025, is expected to grow at a CAGR of 4.91%, driven by dairy producers' focus on preventing aflatoxin M1 carry-over into milk.
By region, Asia Pacific led the market in 2025 with USD 94.98 Million, followed by Europe (USD 83.11 Million), North America (USD 65.30 Million), Latin America (USD 38.58 Million) and the Middle East & Africa (USD 14.84 Million). Asia Pacific's leadership reflects the scale of feed production in China, which was valued at USD 43.69 Million in 2025, and the rapid growth of India, projected at a CAGR of 7.42%. Europe and North America are mature markets where growth is driven primarily by the shift towards higher-value modifiers, which already account for 38.0% of the European market and 36.0% of the North American market, compared with 30.0% globally. Latin America, led by Brazil, is projected to grow at a CAGR of 5.07%, supported by its export-oriented poultry and pork industries.
Competitive Landscape Summary
The market is moderately consolidated. A group of global animal nutrition and health companies, including dsm-firmenich (Mycofix), Alltech (Mycosorb), Kemin Industries (TOXFIN), Trouw Nutrition (Selko TOXO), Cargill (NOTOX), ADM (T5X) and Adisseo (Toxy-Nil, Unike Plus), compete alongside specialised players such as EW Nutrition (Mastersorb), Olmix (MT.X+), Impextraco (Elitox), Phileo by Lesaffre (Safwall) and Anpario (Anpro). Competition centres on proven efficacy against multiple mycotoxins, regulatory authorisation of detoxification claims, technical service and digital risk-assessment tools. Recent ownership changes, notably dsm-firmenich's February 2026 agreement to divest its Animal Nutrition & Health business to CVC Capital Partners and EW Group's 2026 acquisition of Olmix, are reshaping the competitive structure.
Challenges and Opportunities
Key challenges include the variable efficacy of conventional clay binders against non-polar mycotoxins, the cost and duration of regulatory approval for detoxification claims (particularly in the United States and the European Union), and price competition from low-cost binders in Asia and other emerging markets. Opportunities lie in biotransformation technologies, the rapidly expanding feed sectors of Asia Pacific and Latin America, and integrated risk-management offerings that combine testing, digital monitoring and tailored product recommendations.
Future Outlook
The market is expected to add USD 111.84 Million between 2025 and 2032. Asia Pacific will contribute the largest absolute gain of USD 45.03 Million, reflecting growth in feed output in China, India and Southeast Asia. Climate variability, which is broadening the geographic range of aflatoxin and Fusarium toxin risk, together with the tightening of EU guidance values from 2027, is expected to sustain demand for detoxifiers and to accelerate the shift towards multi-mode products that combine adsorption, biotransformation and organ protection.
The Feed Mycotoxin Detoxifiers Market market is projected to grow at a CAGR of 4.7% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Feed mycotoxin detoxifiers are feed additives incorporated into compound feed, premixes or total mixed rations to reduce the absorption, bioavailability or toxicity of mycotoxins in livestock. In the European Union, these products correspond to the functional group "substances for reduction of the contamination of feed by mycotoxins" established by Regulation (EC) No 386/2009 within the technological additives category.
For the purposes of this study, the market includes:
Binders: inorganic adsorbents such as bentonite, montmorillonite, hydrated sodium calcium aluminosilicates (HSCAS), zeolites, diatomaceous earth and activated charcoal, and organic adsorbents such as yeast cell wall-derived glucomannans and beta-glucans, including combinations of the two.
Modifiers: biotransforming agents that convert mycotoxins into less toxic or non-toxic metabolites, including purified enzymes (for example fumonisin esterase) and microorganisms or microbial preparations (for example the trichothecene-degrading strain DSM 11798), together with formulated products in which these act as the principal mode of action.
The study excludes mould inhibitors and feed preservatives (such as propionic acid) that prevent fungal growth but do not act on preformed mycotoxins, laboratory testing kits and services, grain cleaning and sorting equipment, and standalone hepatoprotective or antioxidant additives that are not marketed as mycotoxin detoxifiers. Market values reflect revenue generated from the sale of detoxifier products at the manufacturer level.
Scope of the Study
The study analyses the Global Feed Mycotoxin Detoxifiers Market across the following segmentations, as defined in the market data set:
By Product Type: Binders, Modifiers
By Livestock: Poultry, Swine, Ruminants & Others
By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, with country-level analysis for U.S., Canada, Mexico; Germany, U.K., France, Italy, Spain, Rest of Europe; China, India, Japan, Rest of Asia Pacific; Brazil, Argentina, Rest of Latin America; UAE, Saudi Arabia, South Africa, Rest of MEA
The timeline comprises historic years 2022–2024, base year 2025 and forecast years 2026–2032. All market values are presented in USD Million, and growth rates are expressed as the compound annual growth rate (CAGR) for 2026–2032.
Research Objectives
To estimate and forecast the size of the global feed mycotoxin detoxifiers market in value terms (USD Million) for 2022–2032.
To analyse the market by product type (binders and modifiers) and assess the shift from adsorption-based to biotransformation-based solutions.
To evaluate demand by livestock category (poultry, swine, and ruminants & others) and the species-specific sensitivity to individual mycotoxins.
To quantify regional and country-level demand across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
To identify the drivers, restraints, opportunities, trends and challenges shaping the market, including climate-related changes in mycotoxin prevalence.
To review the regulatory framework governing mycotoxin limits in feed and the authorisation of detoxifying additives in major markets.
To assess the value chain, competitive intensity and macro-environmental factors affecting the industry.
To profile the competitive landscape, including the positioning of leading players and key developments since 2022.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured research process comprising data collection through secondary and primary research, market size estimation using top-down and bottom-up approaches, data triangulation, and validation with industry participants. The process begins with the definition of the market and its segments, proceeds to the compilation of feed production, livestock population and mycotoxin prevalence data, and concludes with the development of a forecast model that reflects the expected evolution of demand, regulation and technology across each region and country.
Secondary Research
Secondary research was used to build an understanding of the market, its value chain and its participants. The principal source types were:
Industry associations: International Feed Industry Federation (IFIF), European Feed Manufacturers' Federation (FEFAC), American Feed Industry Association (AFIA), Association of American Feed Control Officials (AAFCO), and national compound feed associations in Asia and Latin America.
Government and regulatory bodies: European Commission (DG SANTE), European Food Safety Authority (EFSA), US Food and Drug Administration Center for Veterinary Medicine, Canadian Food Inspection Agency, China's Ministry of Agriculture and Rural Affairs, Brazil's Ministry of Agriculture and Livestock (MAPA), the Bureau of Indian Standards, FAO and the Codex Alimentarius Commission.
Company sources: annual reports, investor presentations, product literature and press releases of feed additive manufacturers, as well as published mycotoxin survey data from leading suppliers.
Trade and scientific journals: feed industry publications and peer-reviewed journals covering mycotoxicology, animal nutrition and feed safety.
Paid databases: trade statistics, company financial databases and agricultural production databases.
Primary Research
Primary research was conducted through in-depth interviews with participants on both the supply and demand sides of the market to validate secondary findings and obtain qualitative and quantitative insights.
Supply side: product managers, technical directors, regional sales heads and R&D specialists at detoxifier manufacturers, premix producers and distributors.
Demand side: nutritionists and procurement managers at compound feed mills and integrated poultry, swine and dairy operations, veterinarians, and quality assurance managers.
The objectives of primary research were to validate market size and segment splits, understand pricing and inclusion rates, assess adoption of binders versus modifiers by species and region, and gather views on regulatory, technological and competitive developments.
Market Size Estimation
Bottom-up approach: Country-level compound feed production by species was combined with estimated detoxifier penetration rates (share of feed treated), average inclusion rates (kg per tonne of feed) and average selling prices for binders and modifiers. Country estimates were aggregated to regional and global totals.
Top-down approach: The global market was estimated from the revenues of leading feed additive suppliers attributable to mycotoxin solutions, adjusted for the share of smaller and regional players, and then allocated across regions, product types and livestock segments using penetration and pricing ratios derived from primary research.
Data triangulation: The results of both approaches were compared and reconciled. Where the estimates diverged, assumptions were revisited and validated with industry participants until a consistent estimate was obtained for each segment, region and country.
Forecasting Methodology
The forecast was developed using a factor-based model that projects the base-year market across each segment and geography. Factors considered include growth in compound feed production by species, mycotoxin prevalence and climatic trends, regulatory changes affecting mycotoxin limits and additive authorisation, the pace of adoption of biotransformation technologies, price trends for raw materials such as clays and yeast derivatives, and macroeconomic indicators such as GDP and per-capita consumption of meat, eggs and dairy. Each factor was weighted according to its expected impact over the short, medium and long term.
Assumptions and Limitations
Market values are expressed in nominal USD Million; exchange rate fluctuations are assumed to remain within historical ranges over the forecast period.
Feed production growth by species is assumed to follow current structural trends, without major disruption from disease outbreaks such as African swine fever or highly pathogenic avian influenza beyond historical patterns.
Current and announced regulations, including the revised EU guidance values applicable from July 2027, are assumed to be implemented as published.
Pricing for proprietary products is estimated from average selling prices and may vary by customer size and contract structure.
Revenues of privately held companies are not publicly disclosed and are estimated through primary research and industry benchmarks.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The Global Feed Mycotoxin Detoxifiers Market is moderately consolidated. A small group of global animal nutrition and health companies accounts for a substantial part of the market through broad product portfolios, authorised detoxification claims, proprietary biotechnology and extensive technical service networks. Alongside them, a large number of regional and local suppliers compete primarily with clay-based binders, particularly in price-sensitive markets in Asia Pacific, Latin America and Africa.
Competition is based on demonstrated efficacy against multiple mycotoxins, regulatory approvals, product consistency, price and the ability to provide value-added services such as mycotoxin testing, surveys and digital risk-assessment tools. Leading companies publish large-scale mycotoxin surveys that reinforce their technical credibility, and they increasingly position multi-mode products that combine adsorption, biotransformation and organ or immune support. The competitive structure is in transition, with significant ownership changes in 2025–2026, including the planned divestment of dsm-firmenich's Animal Nutrition & Health business to CVC Capital Partners, the acquisition of Olmix by EW Group, and the formation of the Akralos feed joint venture by Alltech and ADM in North America.
Key Player Positioning
Based on product breadth, technology, geographic reach and market presence, the leading participants can be positioned as follows:
Leaders: dsm-firmenich (Mycofix), Alltech (Mycosorb), Kemin Industries (TOXFIN) and Trouw Nutrition (Selko TOXO). These companies combine broad mycotoxin portfolios with global distribution, long experience in the category and strong technical service capabilities. dsm-firmenich is distinguished by its leadership in biotransformation, with authorised enzyme and microbial products.
Challengers: Cargill (NOTOX), ADM (T5X), Adisseo (Toxy-Nil, Unike Plus), EW Nutrition (Mastersorb) and Olmix (MT.X range). These players leverage large feed, premix or specialty additive businesses, extensive customer access and recent investments in digital tools or acquisitions to expand their position.
Niche players: Impextraco (Elitox), Phileo by Lesaffre (Safwall) and Anpario (Anpro). These companies focus on specific technologies, such as yeast-derived adsorbents or clay-based formulations, or on specific regions, and compete through specialised offerings and regional strength.
Competitor Dashboard
The competitor dashboard assesses each company on four parameters relevant to its position in the feed mycotoxin detoxifiers market: breadth of mycotoxin product portfolio, regional presence, strategic alliances and industry experience.
Threat of New Entrants – Medium
Entry barriers for basic clay binders are low, as raw materials are widely available and production technology is simple, enabling regional suppliers to compete on price.
Barriers are high for products carrying authorised detoxification claims and for biotransformation products, which require proprietary strains or enzymes, extensive efficacy data and lengthy approval processes.
Established players benefit from long-standing relationships with integrators and from global technical service networks.
Bargaining Power of Suppliers – Low
Clays and yeast derivatives are available from multiple sources, limiting supplier leverage.
Leading biotransformation players produce proprietary enzymes and strains in-house, reducing dependence on external suppliers.
Bargaining Power of Buyers – High
Large integrators and feed manufacturers purchase significant volumes and negotiate pricing through tenders and annual contracts.
Switching costs between binder products are low, and buyers can benchmark products through in vitro testing.
Buyers increasingly demand technical support and risk-assessment services as part of the purchase.
Threat of Substitutes – Medium
Preventive measures such as resistant crop varieties, good agricultural practices, grain drying, cleaning and sorting can reduce contamination before it reaches feed.
Diversion of contaminated grain to less sensitive species or non-feed uses serves as an alternative risk-management strategy.
However, no substitute fully eliminates preformed mycotoxins in finished feed, sustaining the need for detoxifiers.
Intensity of Competitive Rivalry – High
A large number of global and regional suppliers compete on efficacy claims, price and service.
Product differentiation is increasingly based on multi-mode formulations, regulatory approvals and digital tools.
Consolidation among leading players is intensifying competition for distribution and key accounts.
Threat of New Entrants: Medium; Low barriers for clays; high barriers for authorised and biotransformation products.
Bargaining Power of Suppliers: Low; Abundant raw materials; in-house production of proprietary actives.
Bargaining Power of Buyers: High; Concentrated purchasing by integrators; low switching costs.
Threat of Substitutes: Medium; Preventive agronomy and grain management reduce but do not eliminate need.
Competitive Rivalry: High; Many suppliers; differentiation through efficacy, approvals and service.
Market estimates by geography (2032)
InsightAsia Pacific leads with $140.01M by 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $57.91M | $70.60M | $86.26M | 4.1% | 21% |
| Europe | $74.42M | $89.16M | $107.13M | 3.7% | 26% |
| Asia Pacific | $80.28M | $106.48M | $140.01M | 5.7% | 34% |
| Latin America | $33.24M | $42.66M | $54.58M | 5.1% | 13% |
| Middle East & Africa | $12.87M | $16.32M | $20.68M | 4.9% | 5% |
| Total | $258.72M | $325.23M | $408.65M | 4.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$408.65M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Binders | $272.68M | 4.0% | 67% |
| Modifiers | $135.97M | 6.3% | 33% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Feed Mycotoxin Detoxifiers Market covering market dynamics, competitive landscape, and strategic outlook.
The Feed Mycotoxin Detoxifiers Market market is projected to reach $408.65M by 2032, growing at 4.7% CAGR. The Binders segment holds the largest share.
The Global Feed Mycotoxin Detoxifiers Market is shaped by a combination of agronomic, regulatory, economic and technological forces. Mycotoxin contamination is an unavoidable consequence of fungal growth in the field and during storage, and its incidence is closely linked to weather conditions. As a result, demand for detoxifiers is structurally supported but also fluctuates with harvest quality. This chapter assesses the factors influencing market growth. The impact scores presented in the growth factor table below are analyst assessments on a scale of 1 to 10, reflecting the relative strength of each factor's influence on market growth in the short (2026–2027), medium (2028–2030) and long (2031–2032) term.
Rising Prevalence and Co-occurrence of Mycotoxins in Feed
The most fundamental driver of the market is the high and increasing contamination of feed raw materials with mycotoxins. The dsm-firmenich World Mycotoxin Survey for January–December 2025, which analysed 25,626 feed samples from 95 countries, reported that contamination levels and average concentrations of all six major mycotoxins (aflatoxins, zearalenone, deoxynivalenol, fumonisins, T-2 toxin and ochratoxin A) increased compared with 2024, with additional regions moving into the extreme-risk category, including North and Central America, South Asia, parts of Europe, and China and Taiwan. The survey's January–September 2025 results showed that 82% of 19,051 samples contained more than one mycotoxin. Similarly, Selko's 2024 Global Mycotoxin Review, covering more than 86,000 samples from 47 countries, detected zearalenone in 66% of samples. Because co-contamination produces additive or synergistic toxic effects that cannot be addressed by a single adsorbent, feed producers are increasingly using broad-spectrum detoxifiers as a routine inclusion rather than a seasonal intervention, supporting consistent volume growth.
Expansion of Global Feed Production and Animal Protein Demand
Detoxifier demand scales directly with compound feed output. According to the 2026 Alltech Agri-Food Outlook, global feed production reached approximately 1.44 billion tonnes in 2025, an increase of 2.9%, produced by 38,837 feed mills in 142 countries. China (330.1 million tonnes), the United States (267.4 million tonnes), Brazil (89.9 million tonnes) and India (57.7 million tonnes) were the leading producers, while broiler feed (400.4 million tonnes) and pig feed (380.9 million tonnes) were the largest species categories. Rising incomes and urbanisation in Asia, Latin America and Africa continue to increase consumption of poultry meat, eggs, pork and dairy, which in turn drives the industrialisation of livestock production. Integrated producers and commercial feed mills operating at scale are more likely to adopt mycotoxin risk-management programmes, including systematic use of detoxifiers, than smallholder systems. This structural shift is a key reason for the above-average growth of Asia Pacific, where the market is projected to grow at a CAGR of 5.66%.
Climate Change Broadening the Geography of Mycotoxin Risk
Changes in temperature and rainfall patterns are altering the distribution of toxigenic fungi. An EFSA-funded modelling study by Battilani et al. (2016) projected that, under a +2°C climate scenario, the aflatoxin B1 risk index for maize in Europe would rise from 38 to 73, and the share of sites exceeding the EU legal limit would increase from about 20% to 39%, with Eastern Europe, the Balkans and the Mediterranean most affected. Aflatoxins, historically associated with tropical and subtropical regions, are therefore becoming a recurring concern in temperate maize-growing areas, while Fusarium toxins such as deoxynivalenol and zearalenone are influenced by wetter conditions at flowering and harvest. Extreme weather events, including droughts and late-season rains, also increase storage-related contamination. This growing unpredictability encourages feed producers in regions that historically used detoxifiers only in high-risk years, such as Northern and Central Europe and North America, to adopt them on a more continuous basis.
Tightening Regulation and Formal Recognition of Detoxifiers
Regulatory frameworks are both raising the bar on permissible mycotoxin levels and creating a formal pathway for detoxification claims. In the European Union, Regulation (EC) No 386/2009 established a dedicated functional group for substances that reduce mycotoxin contamination of feed, under which bentonite (1m558), fumonisin esterase (1m03i) and the trichothecene-degrading strain DSM 11798 (1m01, renewed in March 2026) have been authorised. Commission Recommendation (EU) 2026/1801, which replaces Recommendations 2006/576/EC and 2013/165/EU from 1 July 2027, introduces revised guidance values, such as 0.7 mg/kg of deoxynivalenol in complete feed for pigs. In the United States, the FDA amended 21 CFR 573.485 in 2022 to permit fumonisin esterase in swine and poultry feed, and the Canadian Food Inspection Agency approved a fumonisin-degrading ingredient for swine and poultry in August 2024. These approvals give feed producers confidence in validated products and support premium pricing for modifiers.
Biotransformation Technologies
Enzymes and microorganisms that irreversibly degrade mycotoxins address the main limitation of binders, and their authorisation in the EU, the United States and Canada has created a platform for growth. Modifiers are projected to grow at a CAGR of 6.17%, well above the 3.98% expected for binders. Opportunities exist for suppliers to develop enzymes targeting zearalenone, ochratoxin A and aflatoxins, to improve thermostability for pelleted feed, and to combine biotransformation with adsorption in a single product.
Growth in Emerging Feed Markets
The fastest-growing country markets are in emerging economies, led by India, which is projected to grow at a CAGR of 7.42%. Rapid commercialisation of poultry and dairy production, hot and humid climatic conditions favouring aflatoxin formation, and increasing awareness of feed quality among integrators create significant demand. Local manufacturing reduces cost and improves responsiveness: dsm-firmenich opened a plant in Jadcherla, India in August 2025 that includes a production line for mycotoxin products such as Mycofix Secure and Mycofix Shield.
Integrated Risk Management and Digital Services
Suppliers are differentiating through services that help customers quantify risk and select the appropriate product and dose. Examples include Adisseo's Mycoman platform launched in July 2024, Selko's Mycotoxin Monitor launched in early 2025, and Cargill's Mycotoxin Impact Calculator, supported by a database of more than 400,000 analyses. These tools strengthen customer relationships, encourage routine use of detoxifiers and create opportunities for value-based pricing.
Variable Efficacy of Binders Across Mycotoxins
Clay-based binders, which represent the largest share of the market, are highly effective against polar mycotoxins such as aflatoxins but show limited adsorption of deoxynivalenol, zearalenone, fumonisins and T-2 toxin. In addition, some inorganic adsorbents may bind micronutrients or veterinary drugs at high inclusion rates. Inconsistent field results and the difficulty of demonstrating a return on investment in the absence of acute toxicosis can lead price-sensitive producers to reduce inclusion rates or use detoxifiers only when contamination is confirmed, which moderates volume growth.
Regulatory Complexity and Claim Restrictions
Authorisation requirements differ significantly across markets. In the United States, the FDA Center for Veterinary Medicine treats products marketed to bind mycotoxins as food additives requiring an approved food additive petition, while sodium aluminosilicate and HSCAS are generally recognised as safe only as anticaking agents at up to 2% of feed, without mycotoxin-binding claims. In the European Union, authorisation under Regulation (EC) No 1831/2003 requires extensive in vivo efficacy and safety data for each target species. The cost and time required to secure approvals limit the number of products that can carry detoxification claims, raise barriers for smaller suppliers and slow the commercialisation of new technologies.
Price Pressure in Cost-Sensitive Markets
Feed accounts for the majority of livestock production costs, and margins in poultry and swine production are cyclical. During periods of low profitability, producers scrutinise additive costs closely and often switch to cheaper generic clays. Anpario reported in its 2026 interim results that its toxin binder sales in Asia fell by more than 60%, which it attributed to lower-priced competitors. Such price competition constrains revenue growth for premium multi-component products, particularly in Asia Pacific, Latin America and Africa.
Challenge: Emerging and Modified Mycotoxins
Emerging mycotoxins such as enniatins, beauvericin and moniliformin, and modified (masked) forms such as deoxynivalenol-3-glucoside, are frequently detected but are not covered by most regulatory limits and are difficult to analyse routinely. Their toxicological relevance is not fully established, which complicates risk assessment and the demonstration of product efficacy.
Challenge: Demonstrating Return on Investment
The effects of chronic low-level mycotoxin exposure, such as reduced feed efficiency, impaired immunity and reproductive disorders, are often subclinical and difficult to attribute. Standardised in vitro tests do not always predict in vivo efficacy, and suppliers must invest in species-specific trials and biomarker-based evidence to justify the cost of premium products to producers.
Trend: Multi-Mode "Binder-Plus" Formulations
Product development is moving from single adsorbents towards multi-component formulations that combine clays, yeast cell walls, algae, enzymes, antioxidants and hepatoprotective or immune-supporting ingredients. Products such as Kemin's TOXFIN CARE, Olmix's MT.X+, Alltech's Mycosorb A+ Evo and ADM's T5X range illustrate this approach, which targets a broader spectrum of mycotoxins and supports the animal's recovery from subclinical exposure.
Trend: Industry Consolidation and Portfolio Reshaping
The competitive landscape is being reshaped by large transactions. dsm-firmenich agreed in February 2026 to divest its Animal Nutrition & Health business, which includes the Mycofix range, to CVC Capital Partners; EW Group completed the acquisition of Olmix in 2026; and Alltech and ADM combined their North American feed operations in the Akralos joint venture from February 2026. Consolidation is expected to sharpen focus on specialty additives and intensify competition for distribution access.
The value chain of the feed mycotoxin detoxifiers market comprises four principal stages:
Raw materials and inputs: Mined clays (bentonite, montmorillonite, zeolite, diatomaceous earth), yeast cell walls obtained from brewing and fermentation industries, algae extracts, and fermentation inputs for the production of enzymes and microbial strains. Clay quality varies by deposit, making sourcing and characterisation critical, while biotechnology inputs depend on proprietary strains and fermentation capacity.
Manufacturing and formulation: Activation, purification and micronisation of clays; extraction and processing of yeast cell wall fractions; fermentation, downstream processing and stabilisation of enzymes and microorganisms; and blending into multi-component formulations. Quality control includes in vitro adsorption and degradation testing, while regulatory dossiers require in vivo efficacy data.
Distribution and channels: Products reach users through direct sales to integrators and large feed mills, through premix and specialty nutrition companies that incorporate detoxifiers into premixes, and through regional distributors and veterinary channels serving smaller producers. Technical service, mycotoxin testing and digital risk-assessment tools are increasingly bundled with products.
End users: Commercial compound feed manufacturers, integrated poultry and swine producers, dairy and beef operations, home mixers, and producers of aquaculture, pet and equine feed.
European Union
Regulation (EC) No 1831/2003 sets the framework for the authorisation of feed additives, including efficacy and safety evaluation by EFSA.
Regulation (EC) No 386/2009 created the functional group "substances for reduction of the contamination of feed by mycotoxins" within the technological additives category.
Directive 2002/32/EC on undesirable substances in animal feed sets maximum levels for aflatoxin B1, as amended by Regulation (EU) No 574/2011 (for example, 0.005 mg/kg in compound feed for dairy animals, piglets and young poultry).
Commission Recommendation (EU) 2026/1801 establishes guidance values for deoxynivalenol, zearalenone, ochratoxin A, fumonisins and T-2/HT-2 toxins in feed, replacing Recommendations 2006/576/EC and 2013/165/EU from 1 July 2027.
Authorised detoxifiers include bentonite 1m558 (Implementing Regulation (EU) No 1060/2013), fumonisin esterase 1m03i (Implementing Regulation (EU) 2018/1568), a second fumonisin esterase (Implementing Regulation (EU) 2024/2184) and strain DSM 11798, 1m01 (renewed by Implementing Regulation (EU) 2026/549).
North America
United States: FDA Compliance Policy Guide Sec. 683.100 sets action levels for aflatoxins in animal feeds (20 to 300 ppb depending on species and use); FDA guidance sets levels for fumonisins (2001) and advisory levels for deoxynivalenol (2010). Products marketed to bind mycotoxins are regulated as food additives; 21 CFR 573.485 permits fumonisin esterase in swine and poultry feed.
Canada: The Feeds Regulations, 2024, administered by the Canadian Food Inspection Agency, together with RG-8 Regulatory Guidance on Contaminants in Feed, govern feed safety and mycotoxin levels.
Asia Pacific
China: GB 13078-2017 Hygienical Standard for Feeds, in force since May 2018, sets limits for aflatoxin B1, ochratoxin A, zearalenone, deoxynivalenol, T-2 toxin and fumonisins in feed materials and compound feed. Feed additives must be listed in the Ministry of Agriculture and Rural Affairs Feed Additive Catalogue.
India: Bureau of Indian Standards specifications IS 1374:2007 (poultry feeds, aflatoxin B1 maximum of 20 µg/kg) and IS 2052:2009 (compounded feeds for cattle) set quality requirements. In April 2026, the Delhi High Court quashed FSSAI directions that had made BIS certification mandatory for cattle feed.
Latin America
Brazil: MAPA Normative Instruction No. 13 of 2004 regulates feed additives and includes adsorbents within the technological additives group; mycotoxin adsorbents require registration with technical dossiers. Decree No. 12.031 of 2024 governs feed inspection, and Portaria SDA/MAPA No. 1.412 of 2025 sets aflatoxin limits for dog and cat food from July 2026.
International Standards
Codex Alimentarius: CXC 51-2003 (prevention and reduction of mycotoxin contamination in cereals), CXC 54-2004 (Code of Practice on Good Animal Feeding) and CXC 45-1997 (reduction of aflatoxin B1 in feed for milk-producing animals) provide internationally recognised guidance.
Aug 2022: dsm-firmenich (Biomin); Regulatory approval; US FDA amendment of 21 CFR 573.485 took effect, permitting fumonisin esterase in swine and poultry feed.
Feb 2023: Adisseo; Acquisition; Completed the acquisition of Nor-Feed, a French producer of plant-based specialty feed ingredients.
Jul 2023: Olmix Group; Acquisition; Acquired Yes Sinergy, a Brazilian producer of sugar-cane yeast-based additives, including products addressing mycotoxin effects.
Dec 2023: ADM; Acquisition; Agreed to acquire PT Trouw Nutrition Indonesia and its two premix plants from Trouw Nutrition.
Mar 2024: EW Nutrition; Acquisition; Acquired the BIOMIN BIOSTABIL silage inoculant product line from dsm-firmenich.
Jul 2024: Adisseo; Product launch; Launched Mycoman, a digital mycotoxin management platform covering contamination forecasting, risk assessment and product recommendations.
Aug 2024: dsm-firmenich; Regulatory approval; Received CFIA approval for Mycofix FUMzyme in swine and poultry, the first approved fumonisin-degrading feed ingredient in Canada.
Sep 2024: Anpario plc; Acquisition; Acquired Bio-Vet Inc. (USA) for GBP 5.8 million, expanding its presence in the Americas.
Jan 2025: Trouw Nutrition (Selko); Product launch; Launched Mycotoxin Monitor, a real-time global mycotoxin contamination data tool, at IPPE 2025.
Feb 2025: dsm-firmenich; Divestment; Agreed to sell its stake in the Feed Enzymes Alliance to Novonesis for EUR 1.5 billion; the transaction was completed by June 2025.
Mar 2025: EW Nutrition; Acquisition; Acquired a 52% majority stake in Green Innovation, an Austrian gut-health solutions company.
Apr 2025: Cargill; Product launch; Presented NOTOX as its mycotoxin risk-management brand at the World Mycotoxin Forum.
Jul 2025: Cargill; Acquisition; Made a binding offer to acquire Mig-Plus, a Brazilian premix and feed company, subject to CADE approval.
Aug 2025: dsm-firmenich; Expansion; Opened an Animal Nutrition & Health plant in Jadcherla, India, including a production line for Mycofix Secure and Mycofix Shield.
Sep 2025: Alltech and ADM; Joint venture; Announced a North American feed joint venture combining 44 mills; launched as Akralos effective 1 February 2026.
Oct 2025: Alltech; Product launch; Launched Mycosorb A+ Evo and Mycosorb Evo next-generation mycotoxin binders.
Feb 2026: dsm-firmenich; Divestment; Agreed to divest its Animal Nutrition & Health business, including the Mycofix range, to CVC Capital Partners at an enterprise value of about EUR 2.2 billion; closing expected by end-2026.
Feb 2026: EW Nutrition; Partnership; Strengthened its partnership with GRASP (Brazil), agreeing to raise its stake to full ownership by end-2029.
Aug 2026: EW Group (EW Nutrition); Acquisition; Completed the acquisition of Olmix Group, which continues to operate as a standalone company alongside EW Nutrition.
Political
Government food security and self-sufficiency programmes in Asia and the Middle East support investment in commercial livestock and feed production.
Trade policies and tariffs on feed grains affect sourcing patterns and the mycotoxin profile of imported raw materials.
Economic
Feed grain price volatility influences producers' willingness to pay for premium detoxifiers.
Rising incomes in emerging economies increase demand for animal protein and commercial feed.
Economic losses from reduced animal performance strengthen the cost-benefit case for detoxifiers.
Social
Consumer concern about food safety, including aflatoxin M1 in milk, raises pressure on dairy and food companies to control mycotoxins in feed.
Growing demand for antibiotic-free and welfare-certified production increases attention to gut health and immunity.
Technological
Advances in enzyme engineering and microbial biotechnology are enabling new biotransformation products.
Rapid testing methods and digital risk-management platforms support data-driven product selection.
Improved characterisation of clays enhances binder selectivity and consistency.
Environmental
Climate change is expanding the geographic range of aflatoxin and Fusarium toxin risk.
Extreme weather events increase field and storage contamination.
Mining of clays and sustainability of raw material sourcing are receiving greater scrutiny.
Legal
Mycotoxin limits for feed vary across jurisdictions, requiring market-specific compliance.
Detoxification claims require formal authorisation in the EU and the United States, restricting marketing of unapproved products.
Revised EU guidance values from 2027 will tighten compliance requirements.
Profiles of 106 companies operating in the Feed Mycotoxin Detoxifiers Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
3 interactive charts drawn from the Feed Mycotoxin Detoxifiers Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Feed Mycotoxin Detoxifiers Market By Livestock
Global Feed Mycotoxin Detoxifiers Market By Product Type
Global Feed Mycotoxin Detoxifiers Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
